CAMBRIDGE, Mass.--(BUSINESS WIRE)--Critical Biologics Corporation (CBC) today announced the appointment of Richard Straube, MD as Chief Medical Officer, effective June, 2007.
“Having worked extensively with Rick in the past, I am absolutely delighted in his decision to join us!” said Ashleigh Palmer, CBC’s Chief Executive Officer. “Rick’s experience and expertise in critical care clinical trial design and drug development represents a distinctive core competence and a valuable strategic asset for CBC going forward.”
